Search Results - "Zambrano, Carmen Beato"

SEOM clinical guidelines for cancer anorexia-cachexia syndrome (2023) by Soria Rivas, Ainara, Escobar Álvarez, Yolanda, Blasco Cordellat, Ana, Majem Tarruella, Margarita, Molina Mata, Kevin, Motilla de la Cámara, Marta, del Mar Muñoz Sánchez, Mª, Zafra Poves, Marta, Beato Zambrano, Carmen, Cabezón Gutierrez, Luis

“…Cancer-related anorexia-cachexia syndrome (CACS) is a debilitating condition afflicting up to 80% of advanced-stage cancer patients. Characterized by…”
Get full text

18F-FDG PET/CT in pure testicular Yolk Sac Tumor in adult by García-Gómez, Francisco Javier, Villar-Rodríguez, José Luis, Beato-Zambrano, Carmen, de la Riva-Pérez, Pablo Antonio, Calvo-Morón, María de la Cinta

Get full text

Therapeutic impact and routine application of next-generation sequencing: A single institute study by Hernández-Pacheco Acosta, Rocío, Del Carmen Damas Fuentes, María, Gallego Pena, Nicolás, Soto Rojas, Pilar, Beato Zambrano, Carmen

“…Genomic sequencing of tumor tissues provides information on actionable gene aberrations that have diagnostic and therapeutic significance and may guide…”
Get full text

SEOM-GETTHI clinical guideline for the practical management of molecular platforms (2021) by de la Haba-Rodriguez, Juan, Lloret, Ferran Ferragut, Salgado, Maria Angeles Vaz, Arce, Martín Oré, Gutiérrez, Ana Cardeña, Jiménez, Jesús García-Donas, Zambrano, Carmen Beato, Alonso, Rosa María Rodríguez, López, Rafael López, Salas, Nuria Rodriguez

“…The improvement of molecular alterations in cancer as well as the development of technology has allowed us to bring closer to clinical practice the…”
Get full text

Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis by Cobo Dols, Manuel, Beato Zambrano, Carmen, Cabezón Gutiérrez, Luis, Chicas Sett, Rodolfo, Blancas López-Barajas, María Isabel, García Navalón, Francisco, Fírvida Pérez, José Luis, Serrano Bermúdez, Gala, Togores Torres, Pilar, Delgado Mingorance, Ignacio, Giraldo Marín, Alexandra, Librán Oriol, Anna, Paredes Lario, Alfredo, Sánchez Mauriño, Pedro, Higuera Gómez, Oliver, Moreno Muñoz, Diana, Jiménez López, Antonio Javier, Huerta González, Ibone, Sanz Yagüe, Almudena, Soler López, Begoña

“…Opioid-induced constipation (OIC) can affect up to 63% of all patients with cancer. The objectives of this study were to assess quality of life as well as…”
Get more information

One-year efficacy and safety of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: KYONAL study by Cobo Dols, Manuel, Beato Zambrano, Carmen, Cabezón-Gutiérrez, Luis, Chicas-Sett, Rodolfo, Blancas López-Barajas, María Isabel, García Navalón, Francisco Javier, Fírvida Pérez, José Luis, Serrano Bermúdez, Gala, Togores Torres, Pilar, Delgado Mingorance, Ignacio, Giraldo Marín, Alexandra, Librán Oriol, Anna, Paredes Lario, Alfredo, Sánchez Mauriño, Pedro, Higuera Gómez, Oliver, Moreno Muñoz, Diana, Huerta González, Ibone, Sanz-Yagüe, Almudena, Soler López, Begoña

“…Naloxegol is a peripherally acting µ-opioid receptor antagonist (PAMORA) for treatment of opioid-induced constipation (OIC). The main objective was to analyse…”
Get more information